SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Month: September 2018

    Second Trial Showing Efficacy for Stem Cell Treatment of Dry AMD

    Posted on September 16, 2018 by droberts
  • September 16, 2018

    Second Trial Showing Efficacy for Stem Cell Treatment of Dry AMD

    A second trial begun in 2018 is showing positive results with replacing defective cells leading to vision loss from dry (geographic) macular degeneration. Implanted cells derived from stem cells have been implanted into five patients by researchers from University of Southern California (USC) and the University of California, Santa Barbara. Results at one year have […]

      Also posted in
    • Latest News
    • Research and Developments
  • Gout Associated With Increased Risk of AMD

    Posted on September 6, 2018 by droberts
  • September 6, 2018

    Gout Associated With Increased Risk of AMD

    A recent study by researchers at the University of Alabama at Birmingham School of Medicine, has looked into the association between age-related macular degeneration (AMD) and gout. Gout is a form of arthritis resulting from inflammation in the joints caused by the build-up of uric acid crystals and is associated with oxidative stress. The main […]

      Also posted in
    • Latest News
    • Research and Developments
  • Novel Gene Therapy In Trials for Wet AMD

    Posted on September 2, 2018October 12, 2019 by droberts
  • September 2, 2018

    Novel Gene Therapy In Trials for Wet AMD

    (Updated 10/12/19) Adverum Biotechnologies, Inc. has announced progress with yet another therapy designed to extend the time between anti-VEGF injections for treatment of wet age-related macular degeneration (wAMD). The company’s Investigational New Drug (IND) application has been approved for a multi-center study of ADVM-022, a novel gene therapy candidate for the treatment of wAMD. “We […]

      Also posted in
    • Latest News
    • Research and Developments
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.